Canada approves ALS drug from Amylyx Pharma, as US debates its approval

A drug from Amylyx Pharmaceuticals was just approved in Canada on Monday as a new treatment of the patience with ALS. This same drug awaits extended review in the USA, facing skepticism

Reported by Adam Feuerstein, from STAT News.

Canada approves ALS drug from Amylyx Pharma as U.S. patients await extended review